Draft:Outcome Measures in Rheumatology

  • Comment: NO secondary sourcing on the actual subject. Drmies (talk) 01:56, 6 June 2023 (UTC)
  • Comment: Needs to concretely show, using sources not affiliated with this organisation, that it is independently notable. Tom (LT) (talk) 10:19, 5 December 2022 (UTC)

Outcome Measures in Rheumatology (OMERACT) is an international non-profit research organization based in Ottawa, Ontario. It focuses on developing and endorsing Core Outcome Sets in rheumatology.[1]  == Overview == OMERACT was founded in 1992 by Dr. Maarten Boers, Dr. Peter Brooks, Dr. Peter Tugwell, and Dr. Vibeke Strand. The company conducts research to improve outcomes for patients with autoimmune and musculoskeletal diseases. Since 2002, OMERACT has involved patients in research as Patient Research Partners (PRPs) to include patients’ perspectives in developing core outcome sets. [1]

OMERACT started the OMERACT Patient Research Partner Network, a virtual platform offering information, resources, education, and proven ideas for patients and researchers passionate about patient-centered international rheumatology outcome measurement research.[1]  

As of 2024, OMERACT has 36 working groups, published over 1300 papers, and has held 16 conferences worldwide.

References edit

  1. ^ a b c "OMERACT continues to set standards on research outcomes, enhancing the patient voice". www.mdedge.com. Retrieved 2024-02-06.

External Links            edit

·       Website